Switch to
More onapp

Nureca Ltd

NURECA
Health CarePharmaceuticals
SmallcapWith a market cap of ₹883 cr, stock is ranked 1,096
High RiskStock is 3.03x as volatile as Nifty
891.500.00 (+0.00%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹883 cr, stock is ranked 1,096
High RiskStock is 3.03x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
19.64
PB RatioPB Ratio
4.35
Dividend YieldDiv. Yield
0.34%
Sector PESector PE
35.47
Sector PBSector PB
4.33
Sector Div YldSctr Div Yld
0.91%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Nureca Ltd is engaged in the marketing of home healthcare & wellness products

Financial TrendFinancial statements 

201920202021202261.9999.49216.27263.256.246.3946.3844.97
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Closure of trading window 
Announced OnSep 30, 2022

Reference to our letter dated September 29, 2022, wherein we have informed that the trading window for dealing in equity shares of the Company will be closed from September 30, 2022 (Friday) till the completion of 48 hours afterthe declaration of unaudited financial results of the Company for the quarter and half year ending September 30, 2022. It is hereby clarified that the trading window shall be closed after the business hours on September 30, 2022(Friday). | Download

Reference to our letter dated September 29, 2022, wherein we have informed that the trading window for dealing in equity shares of the Company will be closed from September 30, 2022 (Friday) till the completion of 48 hours afterthe declaration of unaudited financial results of the Company for the quarter and half year ending September 30, 2022. It is hereby clarified that the trading window shall be closed after the business hours on September 30, 2022(Friday). | Download

Closure of trading window 
Announced OnSep 29, 2022

Nureca Limited has informed the Exchange about Closure of trading window | Download

Nureca Limited has informed the Exchange about Closure of trading window | Download

Cash Dividend 
Ex. DateFeb 24, 2022

Interim • Div/Share: ₹ 3

See all events